Compare MARPS & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MARPS | AIDX |
|---|---|---|
| Founded | 1956 | N/A |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Oil & Gas Production | Precision Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9M | 9.2M |
| IPO Year | N/A | N/A |
| Metric | MARPS | AIDX |
|---|---|---|
| Price | $4.81 | $0.82 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.1K | ★ 241.9K |
| Earning Date | 02-13-2026 | N/A |
| Dividend Yield | ★ 6.95% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.75 | $0.83 |
| 52 Week High | $6.49 | $14.09 |
| Indicator | MARPS | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 47.23 | 24.43 |
| Support Level | $4.76 | N/A |
| Resistance Level | $5.17 | $1.66 |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 28.91 | 1.80 |
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.